Recent Blog Articles
Taking up adaptive sports
Cutting and self-harm: Why it happens and what to do
Discrimination at work is linked to high blood pressure
Pouring from an empty cup? Three ways to refill emotionally
Give praise to the elbow: A bending, twisting marvel
Sneezy and dopey? Seasonal allergies and your brain
The FDA relaxes restrictions on blood donation
Apps to accelerometers: Can technology improve mental health in older adults?
Swimming and skin: What to know if a child has eczema
A muscle-building obsession in boys: What to know and do
Charlie Schmidt
Editor, Harvard Medical School Annual Report on Prostate Diseases
Charlie Schmidt is an award-winning freelance science writer based in Portland, Maine. In addition to writing for Harvard Health Publishing, Charlie has written for Science magazine, the Journal of the National Cancer Institute, Environmental Health Perspectives, Nature Biotechnology, and The Washington Post.
Posts by Charlie Schmidt
Charlie Schmidt
Hormonal therapy for aggressive prostate cancer: How long is enough?
Charlie Schmidt
Long-term statin use protects against prostate cancer death
Charlie Schmidt
Smoking tied to more aggressive prostate cancer
Charlie Schmidt
Investigators unveil metastatic prostate cancer’s genomic landscape
Charlie Schmidt
A new option for immunotherapy in metastatic prostate cancer
Charlie Schmidt
Q&A with Dr. Daniel Rukstalis on prostatic urethral lift for enlarged prostates
Charlie Schmidt
New blood test may someday help guide the best treatment for aggressive prostate cancer
Men's Health
New blood test guides researchers toward the best treatment for aggressive prostate cancer
Men's Health
Influential task force issues new recommendations on prostate cancer screening
Men's Health
Diagnostic MRIs allow some men flagged by PSA screening to avoid a biospy, new study shows
Charlie Schmidt
New study once again casts doubt on PSA screening
Cancer
A mix of treatments may extend life for men with aggressive prostate cancer
Men's Health
A mix of treatments may extend life for men with aggressive prostate cancer
Cancer
FDA approves new drug for men at high risk of prostate cancer spread
Men's Health
FDA approves new drug for men at high risk of prostate cancer spread
Cancer
Newer drugs are improving survival for men with metastatic prostate cancer
Men's Health
New study downplays potential risk of dementia and Alzheimer’s disease among elderly men treated with hormonal therapy for prostate cancer
Cancer
Study investigates treatment regret among prostate cancer survivors
Men's Health
Study investigates treatment regret among prostate cancer survivors
Men's Health
New study supports lifesaving benefits from PSA screening
Charlie Schmidt
Strong study shows no link between vasectomy and prostate cancer
Charlie Schmidt
Strong study shows no link between vasectomy and prostate cancer
Cancer
Combination hormonal therapy boosts survival in men with aggressive prostate cancer
Charlie Schmidt
